In2Pharma
  • Home
  • Services
    • Regulatory Affairs
    • Quality Assurance
    • Publicity and Compliance
    • Medical writing & training
    • Vigilance
  • About Us
  • News
  • Contact
Select Page
New measures to limit unavailability of medicines – suspended

New measures to limit unavailability of medicines – suspended

by In2Pharma | Sep 25, 2019 | News

Belgium Article 3, 2 °, of the Law of April 7th 2019 on unavailability was suspended by the Constitutional Court on July 18th 2019. This judgment means that wholesaler-distributors are no longer limited to the distribution of medicines to pharmacies and other Belgian...

Recent Posts

  • Update Notification Form “Meldpunt”
  • Planned legislative updates NL
  • Update RD 06.09.2017 pregabalin/gabapentin
  • Update New Inspection Platform GDP – FAMHP
  • Luxembourg tightens rules on nicotine pouches and novel nicotine products from 2026  

Follow Us

  • Facebook
  • LinkedIn
An IQVIA Business

IQVIA Logo
IQVIA is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries and is dedicated to delivering actionable insights and accelerating innovations.

www.iqvia.com

Contact Us

Privacy Policy | Your Privacy Choices | Cookie Policy | BTW BE 895730662 | +32 16 89 16 00| info@in2pharma.com |Terloonststraat 22, 1910 Kampenhout, België